EGLN2 and colorectal carcinoma: In our current study, we uncover that PHD1 silencing does not affect the colony formation capacity and tumor growth under basal conditions, but it increases sensitivity of CRC cells toward the cytostatic effects of chemotherapeutic drugs such as 5-FU, SN-38, or oxaliplatin in vitro and in vivo.